At a major European pharmaceutical manufacturing site, the arrival of summer triggered significant operational anxiety. The chilled water system, vital for maintaining strict temperature and humidity in production areas, appeared to be reaching its absolute limit. Faced with the risk of production non-conformity and the potential loss of entire batches, the site team prepared to invest in new chiller systems. This was the default answer: a multi-million-euro capital investment driven by a need for reassurance during the budget cycle.